HSV
23 September 2010. Related: H.
HSV – Herpes Simplex Virus. HSV-1 is the virus mainly associated with cold sores on your lips or faces. HSV-2 is the virus mainly associated with genital herpes. The viruses are very similar.
23 September 2010. Related: H.
HSV – Herpes Simplex Virus. HSV-1 is the virus mainly associated with cold sores on your lips or faces. HSV-2 is the virus mainly associated with genital herpes. The viruses are very similar.
23 September 2010. Related: B.
boosted-PI – a protease inhibitor taken with an additional dose of ritonavir. The ritonavir boost levels of the protease inhibitor by either increasing the initial drugs levels or reducing how quickly or reducing how quickly it is removed by your …
23 September 2010. Related: A.
antiretrovirals – the common name for any HIV drugs. HIV is a retrovirus, so drugs to fight HIV are called antiretrovirals. Also abbreviated to ARVs.
23 September 2010. Related: A.
abstract – in research, a short summary of a study (usually about 350 words)
17 September 2010. Related: News, Other reports, Publications.
This supplement to the September/October issue of HIV Treatment Bulletin is a non-technical summary from the recent 18th World AIDS Conference held in Vienna. The electronic versions (online and PDF file) include hyperlinks to the original studies on the conference …
15 September 2010. Related: Estonian, Translations.
Please click title link for the download page.
1 September 2010. Related: Advocates, HIV positive people, Resources.
START LTNP leaflet PDF file (60 Kb) The START study – if you are a LTSP… Is your CD4 above 500 without treatment? Are you a long-term slow progressor? This leaflet explains why HIV treatment might be a good idea …
1 September 2010. Related: Advocates, HIV positive people, Resources.
START newly diagnosed leaflet PDF (60 Kb) The START study – if you have been recently diagnosed… Do you have a CD4 count over 500? Were you recently diagnosed? Are you not yet on HIV treatment? This leaflet explains why …
26 August 2010. Related: News.
We lead our coverage from the IAS conference in Vienna with an analysis of the Caprisa 004 trial. In terms of conference headlines, the biggest news came from the results of a prevention study called Caprisa 004. This study reported …
26 August 2010. Related: News.
In this issue we lead with reports from the 18th International AIDS Conference, which took place in Vienna in July. As we explain in our introduction, access to treatment, to which there are many barriers – including unjust legislation, donor …
17 August 2010. Related: D.
dyspepsia – a range of symptoms related to digestion problems that can include pain, nausea, heart burn. vomiting and pain in the stomach or upper intestine.
1 August 2010. Related: S.
specificity – when referring to the accuracy of a test result, specificity refers to the proportion of people who do not have an illness or disease who have a negative test result. If a test has low specificity, the concern …
1 August 2010. Related: S.
sensitivity – when referring to the accuracy of a test result, sensitivity refers to the proportion of people with an illness or disease who have a positive test result. If a test has low sensitivity, then false-negative results are the …
15 July 2010. Related: News.
Updated guide – HIV treatment explained using everyday language.
1 July 2010. Related: News, Other reports, Publications.
Pipeline report 2010: launched at IAS conference in Vienna HIV, tuberculosis, and viral hepatitis: drugs, diagnostics, vaccines, immune-based therapies, and preventive technologies in development This year i-Base is partnering with Treatment Action Group (TAG) to produce a pipeline report on …
29 June 2010. Related: S.
somnolence – feeling sleepy or drowsy, especially during the day.
4 June 2010. Related: Advocacy and learning materials.
START… and why the time is now? Simon Collins of HIV i-Base looks at an important and exciting new study, which needs your help. The START study (Strategic Timing of Antiretroviral Therapy) is exploring when to start treatment and many …
4 June 2010. Related: Advocacy and learning materials.
The START study – if your CD4 is over 500 off-treatment… Simon Collins, HIV i-Base An important new study is enrolling in the UK and needs your help. The START study (Strategic Timing of AntiRetroviral Therapy) looks at when to …